tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Matthew Harrison, 398 are a HOLD (36.41%), 609 are a BUY (55.72%), 86 are a SELL (7.87%).
Analyst Matthew Harrison, currently employed at MORGAN STANLEY, carries an average stock price target met ratio of 63.81% that have a potential upside of 30.38% achieved within 308 days.
Matthew Harrison’s has documented 2,127 price targets and ratings displayed on 101 stocks. The coverage is on Healthcare, Technology, Basic Materials, Energy, Industrials, Consumer Cyclical sectors.
Most recent stock forecast was given on AVIR, Atea Pharmaceuticals at 13-Aug-2026.
Analyst best performing recommendations are on CMRX (CHIMERIX).
The best stock recommendation documented was for CMRX (CHIMERIX) at 2/23/2016. The price target of $5 was fulfilled within 1 day with a profit of $0.54 (12.11%) receiving and performance score of 121.08.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 28-Mar-2024
$5
$3.93 (367.29%)
$10
29 days ago
(17-Aug-2026)
0/4 (0%)
$3.9 (354.55%)
Buy Since 29-Oct-2020
$8
3 months 7 days ago
(08-Jun-2026)
0/16 (0%)
$4.24 (112.77%)
Buy Since 10-May-2022
$5
$3.98 (390.20%)
$8
1 years 2 months 26 days ago
(20-Jun-2025)
0/13 (0%)
$2.23 (80.51%)
Buy Since 08-Nov-2024
$8
$6.98 (684.31%)
$6
1 years 6 months 22 days ago
(24-Feb-2025)
0/2 (0%)
$6.4 (400.00%)
Buy Since 13-Mar-2024
$13
$9.26 (247.59%)
2 years 6 months 2 days ago
(13-Mar-2024)
0/1 (0%)
$9.1 (233.33%)
Which stock is Matthew Harrison most bullish on?
Which stock is Matthew Harrison most reserved on?
What Year was the first public recommendation made by Matthew Harrison?
